Paclitaxel Polymer Micelles + Gemcitabine + Lenvatinib for sarcoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Jan 2026: Trial registered, NCT07359053

The trials

NCT07359053: MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced Sarcoma

State
Under way
Phase
Phase 2
People
46 planned
Started
25 Dec 2025
Primary completion
30 Sep 2027
Arms
bone sarcoma
Results
None posted
  1. 22 Jan 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.